Sun Pharma Advanced Research Company Limited (BOM:532872)

Market Cap	63.90B +49.0%
Revenue (ttm)	19.09B +2,856.0%
Net Income	15.84B
EPS	48.80
Shares Out	n/a
PE Ratio	4.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,544
Open	197.70
Previous Close	190.70
Day's Range	191.20 - 197.70
52-Week Range	108.20 - 289.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 2, 2026

About BOM:532872

Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. It develops Sezaby, a benzyl alcohol and propylene glycol free formulation of phenobarbital sodium injection for the treatment of neonatal seizures; SPARC-121, a novel topical agent for the treatment of Alopecia Areata; and SPARC-122, an anti-MUC1 ADC for treatment of multiple cancer indications. The company is also involved in the development of PDP-716 for treatment of open-angle glaucoma. Sun Pharma Ad...

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 279
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532872

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 7, 2026

Data Sources Report a data error